Literature DB >> 29173259

Optimizing associated liver partition and portal vein ligation for staged hepatectomy outcomes: Surgical experience or appropriate patient selection?

Ibrahim Al Hasan1, Mauro Enrique Tun-Abraham1, Kerollos N Wanis1, Carlos Garcia-Ochoa1, Mark A Levstik1, Bandar Al-Judaibi1, Roberto Hernandez-Alejandro1.   

Abstract

BACKGROUND: Early reports of associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) outcomes have been suboptimal. The literature has confirmed that learning curves influence surgical outcomes. We have 54 months of continuous experience performing ALPPS with strict selection criteria. This study aimed to evaluate the impact of the learning curve on ALPPS outcomes.
METHODS: We retrospectively compared patients who underwent ALPPS between April 2012 and March 2016. Patients were grouped into 2 24-month (early and late) periods. All candidates had a high tumour load requiring staged hepatectomy after chemotherapy response, a predicted future liver remnant (FLR) less than 30% and good performance status.
RESULTS: Thirty-three patients underwent ALPPS during the study period: 16 in the early group (median age 65 yr, mean body mass index [BMI] 27) and 17 in the late group (median age 60 yr, mean BMI 25). Bilobar disease was comparable in both groups (94% v. 88%, p > 0.99). Duration of surgery was not statistically different. Intraoperative blood loss and need for transfusion were significantly lower in the late group (200 ± 109 mL v. 100 ± 43 mL, p < 0.05). The late group had a higher proportion of monosegment ALPPS (4:1). There were no deaths within 90 days in either cohort. Rates of postoperative complications were not statistically significant between groups. The R0 resection rate was similar. The entire 1-year disease-free and overall survival were 52% and 84%, respectively.
CONCLUSION: Excellent results can be obtained in innovative complex surgery with careful patient selection and good technical skills. Additionally, the learning curve brought confidence to perform more complex procedures while maintaining good outcomes.

Entities:  

Mesh:

Year:  2017        PMID: 29173259      PMCID: PMC5726970          DOI: 10.1503/cjs.005817

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  27 in total

1.  Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach.

Authors:  Eduardo de Santibañes; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

2.  The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.

Authors:  Silvio Balzan; Jacques Belghiti; Olivier Farges; Satoshi Ogata; Alain Sauvanet; Didier Delefosse; François Durand
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

3.  Vessel identifications tags for open or laparoscopic associating liver partition and portal vein ligation for staged hepatectomy.

Authors:  Raffaele Brustia; Olivier Scatton; Fabiano Perdigao; Sanaa El-Mouhadi; François Cauchy; Olivier Soubrane
Journal:  J Am Coll Surg       Date:  2013-12       Impact factor: 6.113

4.  Is partial-ALPPS safer than ALPPS? A single-center experience.

Authors:  Henrik Petrowsky; Georg Györi; Michelle de Oliveira; Mickaël Lesurtel; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2015-04       Impact factor: 12.969

5.  ALPPS: Adverse Outcomes Demand Clear Justification in an Era of Improving Survival for Colorectal Liver Metastases.

Authors:  Sanjeev Rohatgi; Ewen M Harrison; James J Powell; Stephen J Wigmore
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

6.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

7.  Segment 4: a Key Point of ALPPS Procedure.

Authors:  Giuseppe Maria Ettorre; Nicola Guglielmo; Roberto Luca Meniconi; Giovanni Battista Levi Sandri; Marco Colasanti; Giovanni Vennarecci
Journal:  Ann Surg       Date:  2017-12       Impact factor: 12.969

8.  Inverting the ALPPS paradigm by minimizing first stage impact: the Mini-ALPPS technique.

Authors:  Eduardo de Santibañes; Fernando A Alvarez; Victoria Ardiles; Juan Pekolj; Martin de Santibañes
Journal:  Langenbecks Arch Surg       Date:  2016-04-15       Impact factor: 3.445

9.  ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis.

Authors:  Erik Schadde; Victoria Ardiles; Ksenija Slankamenac; Christoph Tschuor; Gregory Sergeant; Nadja Amacker; Janine Baumgart; Kris Croome; Roberto Hernandez-Alejandro; Hauke Lang; Eduardo de Santibaňes; Pierre-Alain Clavien
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

10.  Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry.

Authors:  Erik Schadde; Dimitri Aristotle Raptis; Andreas A Schnitzbauer; Victoria Ardiles; Christoph Tschuor; Mickaël Lesurtel; Eddie K Abdalla; Roberto Hernandez-Alejandro; Elio Jovine; Marcel Machado; Massimo Malago; Ricardo Robles-Campos; Henrik Petrowsky; Eduardo De Santibanes; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2015-11       Impact factor: 12.969

View more
  3 in total

Review 1.  The role of associating liver partition and portal vein ligation for staged hepatectomy in the management of patients with colorectal liver metastasis.

Authors:  Juan Glinka; Victoria Ardiles; Juan Pekolj; Eduardo de Santibañes; Martin de Santibañes
Journal:  Hepatobiliary Surg Nutr       Date:  2020-12       Impact factor: 7.293

Review 2.  Outcomes of staged hepatectomies for liver malignancy.

Authors:  Naif A Albati; Ali A Korairi; Ibrahim Al Hasan; Helayel K Almodhaiberi; Abdullah A Algarni
Journal:  World J Hepatol       Date:  2019-06-27

3.  Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study.

Authors:  Zhenfeng Deng; Zongrui Jin; Yonghui Qin; Mingqi Wei; Jilong Wang; Tingting Lu; Ling Zhang; Jingjing Zeng; Li Bao; Ya Guo; Minhao Peng; Banghao Xu; Zhang Wen
Journal:  World J Surg Oncol       Date:  2021-03-30       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.